CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MG
Product details
Registration number: SIN15717P
Classification: Prescription Only
Active ingredients: Isavuconazonium sulfate 372.6mg eqv Isavuconazole
Strength: 200 mg
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: PFIZER PRIVATE LIMITED
ATC code: J02AC05
HSA approval date: 13 June 2019
Manufacturer(s): Simtra US LLC
Manufacturing country/countries: UNITED STATES
What are the HSA registration number and classification for CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15717P
Classification: Prescription Only
What active ingredients and strength are recorded for CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Isavuconazonium sulfate 372.6mg eqv Isavuconazole
Strength: 200 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MG?
According to the HSA dataset updated 7 August 2026:
Registrant: PFIZER PRIVATE LIMITED
Which manufacturers and countries are listed for CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Simtra US LLC
Manufacturing country/countries: UNITED STATES
Where can I look up CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15717P or the exact product name CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MG. The general register link does not preselect this product.
What are the source dates for this CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CRESEMBA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 200MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15717P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)